Omnicell Inc
Change company Symbol lookup
Select an option...
OMCL Omnicell Inc
BOAS BOA Acquisition Corp
ESBA Empire State Realty OP LP
ASGN ASGN Inc
CMS CMS Energy Corp
POWRU Powered Brands
VLDRW Velodyne Lidar Equity Warrants Exp 29 Sep 2025 *W EXP 09/29/2025
JPM JPMorgan Chase & Co
UVV Universal Corp
LNC Lincoln National Corp
Go

Health Care : Health Care Technology | Small Cap Growth
Company profile

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

Closing Price
$145.69
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
337,434
0

Display:

Providers:

UpdateCancel
6 providers
January 05, 2022
Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full-year 2021, after market on Monday...(BusinessWire)

January 04, 2022
Omnicell Acquires MarkeTouch Media

--Accelerates Software-as-a-Service ("SaaS") technology roadmap Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has acquired pharmacy...(BusinessWire)

December 29, 2021
Omnicell Completes Acquisition of ReCept

--Expected to be accretive to Omnicell's non-GAAP EBITDA first quarter of 2023 Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, has completed the previously...(BusinessWire)

December 02, 2021
Omnicell to Acquire ReCept

--Addresses significant need for access to and management of complex medications, expected to improve profitability and patient care Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health...(BusinessWire)

November 22, 2021
Omnicell to Present at Upcoming Investor Conferences

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conferences: (BusinessWire)

November 10, 2021
Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, and Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion...(BusinessWire)

November 02, 2021
Tucson VA Medical Center Selects Omnicell's Central Pharmacy Dispensing Service to Enhance Medication Inventory Management

Omnicell, Inc. (Nasdaq: OMCL) ("Omnicell" or the "Company"), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Tucson VA Medical Center has chosen the Company's Central...(BusinessWire)

Omnicell Announces Financial Results for Third Quarter 2021

Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.